Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases
- PMID: 36128412
- PMCID: PMC9474938
- DOI: 10.1093/ofid/ofac210
Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases
Abstract
Group A Streptococcus (Strep A) is responsible for a significant global health and economic burden. The recent prioritization of Strep A vaccine development by the World Health Organization has prompted global research activities and collaborations. To progress this prioritization, establishment of robust surveillance for Strep A to generate updated regional disease burden estimates and to establish platforms for future impact evaluation is essential. Through the activities of the Strep A Vaccine Global Consortium (SAVAC), we have refined and harmonized surveillance protocols for 7 Strep A disease endpoints with a view that these will form part of surveillance standards for ongoing research and public health activities.
Keywords: Streptococcus pyogenes; epidemiology; group A Streptococcus; surveillance.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. H. C. M. has received funding from MSD under the Merck Investigator Studies Program, outside the submitted work. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- Cannon JW, Jack S, Wu Y, et al. . An economic case for a vaccine to prevent group A Streptococcus skin infections. Vaccine 2018; 36:6968–78. - PubMed
-
- Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685–94. - PubMed
-
- Hand RM, Snelling TL, Carapetis JR.. 40: Group A Streptococcus. In: Ryan ET, Hill DR, Solomon T, et al., eds. Hunter’s Tropical Medicine and Emerging Infectious Diseases, 10th ed. London: Elsevier; 2020:429–38.
-
- White A. WHO resolution on rheumatic heart disease. Eur Heart J 2018; 39:4233. - PubMed
LinkOut - more resources
Full Text Sources
